CNSX:BOSS

Global X Founder-Run Companies ETF Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume189,964 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Global X Founder-Run Companies ETF (CNSX:BOSS) Vs. THCX, GLH, ACG, HC, BIO, and BBM

Should you be buying BOSS stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Global X Founder-Run Companies ETF, including (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Bio-Rad Laboratories (BIO), and Blueberries Medical (BBM).

Global X Founder-Run Companies ETF (CNSX:BOSS) and (THCX.V) (CVE:THCX) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, profitability, risk and valuation.

Earnings and Valuation

This table compares Global X Founder-Run Companies ETF and (THCX.V)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global X Founder-Run Companies ETFN/AN/AN/AN/AN/A
(THCX.V)N/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations for Global X Founder-Run Companies ETF and (THCX.V), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global X Founder-Run Companies ETF0000N/A
(THCX.V)0000N/A

Profitability

This table compares Global X Founder-Run Companies ETF and (THCX.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global X Founder-Run Companies ETFN/AN/AN/A
(THCX.V)N/AN/AN/A

31444 (CNSX:GLH) and Global X Founder-Run Companies ETF (CNSX:BOSS) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, valuation, profitability, risk and dividends.

Earnings & Valuation

This table compares 31444 and Global X Founder-Run Companies ETF's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
31444N/AN/AN/AN/AN/A
Global X Founder-Run Companies ETFN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings for 31444 and Global X Founder-Run Companies ETF, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
314440000N/A
Global X Founder-Run Companies ETF0000N/A

Profitability

This table compares 31444 and Global X Founder-Run Companies ETF's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
31444N/AN/AN/A
Global X Founder-Run Companies ETFN/AN/AN/A

438280 (CNSX:ACG) and Global X Founder-Run Companies ETF (CNSX:BOSS) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, valuation, profitability, risk and dividends.

Earnings & Valuation

This table compares 438280 and Global X Founder-Run Companies ETF's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
438280N/AN/AN/AN/AN/A
Global X Founder-Run Companies ETFN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings for 438280 and Global X Founder-Run Companies ETF, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
4382800000N/A
Global X Founder-Run Companies ETF0000N/A

Profitability

This table compares 438280 and Global X Founder-Run Companies ETF's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
438280N/AN/AN/A
Global X Founder-Run Companies ETFN/AN/AN/A

815446 (CNSX:HC) and Global X Founder-Run Companies ETF (CNSX:BOSS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends and valuation.

Earnings & Valuation

This table compares 815446 and Global X Founder-Run Companies ETF's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
815446N/AN/AN/AN/AN/A
Global X Founder-Run Companies ETFN/AN/AN/AN/AN/A

Profitability

This table compares 815446 and Global X Founder-Run Companies ETF's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
815446N/AN/AN/A
Global X Founder-Run Companies ETFN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings for 815446 and Global X Founder-Run Companies ETF, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
8154460000N/A
Global X Founder-Run Companies ETF0000N/A

Bio-Rad Laboratories (CNSX:BIO) and Global X Founder-Run Companies ETF (CNSX:BOSS) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability and dividends.

Valuation & Earnings

This table compares Bio-Rad Laboratories and Global X Founder-Run Companies ETF's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A
Global X Founder-Run Companies ETFN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Bio-Rad Laboratories and Global X Founder-Run Companies ETF, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bio-Rad Laboratories0000N/A
Global X Founder-Run Companies ETF0000N/A

Profitability

This table compares Bio-Rad Laboratories and Global X Founder-Run Companies ETF's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bio-Rad LaboratoriesN/AN/AN/A
Global X Founder-Run Companies ETFN/AN/AN/A

Global X Founder-Run Companies ETF (CNSX:BOSS) and Blueberries Medical (CNSX:BBM) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, dividends, valuation and earnings.

Valuation & Earnings

This table compares Global X Founder-Run Companies ETF and Blueberries Medical's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global X Founder-Run Companies ETFN/AN/AN/AN/AN/A
Blueberries MedicalN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations for Global X Founder-Run Companies ETF and Blueberries Medical, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Global X Founder-Run Companies ETF0000N/A
Blueberries Medical0000N/A

Profitability

This table compares Global X Founder-Run Companies ETF and Blueberries Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Global X Founder-Run Companies ETFN/AN/AN/A
Blueberries MedicalN/AN/AN/A


Global X Founder-Run Companies ETF Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
THCX
(THCX.V)
0.6$5.30flatC$0.00N/A0.00High Trading Volume
GLH
31444
0.4N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ACG
438280
0.6N/AN/AC$0.00N/A0.00Gap Down
HC
815446
0.5N/AN/A$0.00N/A0.00Gap Down
BIO
Bio-Rad Laboratories
0.5N/AN/A$0.00N/A0.00High Trading Volume
BBM
Blueberries Medical
0.6N/AN/A$0.00N/A0.00High Trading Volume
LOVE
Cannara Biotech
0.7N/AN/A$0.00N/A0.00High Trading Volume
CALI
China Auto Logistics
1.3N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
MJ
ETFMG Alternative Harvest ETF
0.5N/AN/A$0.00N/A0.00News Coverage
Gap Down
LHS
Liberty Health Sciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
Gap Up
LIB
Liberty Leaf
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
MMEN
Medmen Enterprises
0.6N/AN/A$0.00N/A0.00High Trading Volume
RQB
Ravenquest Biomed
0.6N/AN/A$0.00N/A0.00High Trading Volume
TGIF
SoFi Weekly Income ETF
0.6N/AN/A$0.00N/A0.00High Trading Volume
Valeant Pharmaceuticals International logo
VRX
Valeant Pharmaceuticals International
0.5$30.80flatC$0.00N/A0.00
VRT
Vertiv
0.5N/AN/A$0.00N/A0.00Gap Down
This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.